Suchergebnisse - "2494G1JF75"

PubPharm (118)

1

Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets

enthalten in: Antimicrobial agents and chemotherapy | 2011

von Decloedt, E. | McIlleron, H. | Smith, P. | +3

CommentIn: Expert Rev Anti Infect Ther. 2011 Dec;9(12):1115-8. - PMID 22114961

2

Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities

enthalten in: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | 2011

von Peixoto, M. | Pilotto, J. | Stoszek, S. | +7

3

GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system

enthalten in: Antimicrobial agents and chemotherapy | 2011

von Hruz, P. | Yan, Q. | Tsai, L. | +4

4

Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2011

von van Zyl, G. | van Mens, T. | McIlleron, H. | +9

5

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy

enthalten in: AIDS (London, England) | 2011

von Chadwick, E. | Yogev, R. | Alvero, C. | +8

6

The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium

enthalten in: HIV medicine | 2011

von Israr, M. | Mitchell, D. | Alam, S. | +3

7

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa : a cost-effectiveness analysis of the OCTANE trial

enthalten in: AIDS (London, England) | 2011

von Ciaranello, A. | Lockman, S. | Freedberg, K. | +69

8

Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir

enthalten in: Pharmacotherapy | 2011

von Dlamini, J. | Hu, Z. | Somaroo, H. | +4

9

Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis

enthalten in: Antiviral therapy | 2011

von McIlleron, H. | Ren, Y. | Nuttall, J. | +8

10

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

enthalten in: Antiviral research | 2010

von Pistell, P. | Gupta, S. | Knight, A. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]